You are here

  • Home
  • Archive
  • Volume 91, Issue 12
  • Intravitreal bevacizumab (Avastin) for the treatment of choroidal neovascularization in age-related macular degeneration: results from 118 cases

Article info

Article menu
Download PDFPDF
Letter
Intravitreal bevacizumab (Avastin) for the treatment of choroidal neovascularization in age-related macular degeneration: results from 118 cases

Authors

  1. Dr Richard S B Newsom, Southampton Eye Unit, Tremona Road, Southampton S016 6YD, UK; Richard.Newsom{at}suht.swest.nhs.uk
View Full Text

Citation

Madhusudhana KC, Hannan SR, Williams CPR, et al
Intravitreal bevacizumab (Avastin) for the treatment of choroidal neovascularization in age-related macular degeneration: results from 118 cases
British Journal of Ophthalmology 2007;91:1716-1717.

Publication history

  • Accepted February 23, 2007
  • First published November 16, 2007.
Online issue publication 
March 22, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2007 BMJ Publishing Group